Par Health Usa, Llc: Brevital Sodium (methohexital Sodium), 500 Mg/vial
Par Health is voluntarily recalling two specific lots of Brevital® Sodium 500 mg/vial, an injectable medication used during anesthesia, because cellulose particles were found in the product. The recall affects hospitals nationwide. The medication lots involved are being removed from distribution at the hospital level.
- Recalling firm
- Par Health USA, LLC
- Product
- Brevital Sodium (methohexital sodium), 500 mg/vial, Rx only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-105-01.
- Reason
- Presence of Particulate Matter
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-10-08
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/fd9660f2-effb-42e2-be56-a182e5f150f4